99.9 atom%D

Item number1077-10X0.75ML
Molecular weight86,94 g/mol
Quantity 10x0.75ml
CoA / MSDSRetrieve CoA
Retrieve MSDS
Show Safety Data Sheet online


Please log in.

Safety Data Sheetaccording to Regulation (EC) No 1907/2006 (REACH)
Classifications according to Regulation (EC) No 1272/2008.
Printdate 29.02.2024
Product name:Dichloromethane-d2
Catalog No.:1077-10X0.75ML
Relevant identified uses of the substance or mixtureIdentified: Laboratory chemical
uses: R&D
Uses advised against:HPC Standards GmbH
Permoserstrasse 15

04318 Leipzig

Tel. +49 341 5295 183
Fax. +49 341 5295 182
HAZARDS IDENTIFICATION2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Skin irritation (Category 2), H315
Eye irritation (Category 2), H319
Carcinogenicity (Category 2), H351
Specific target organ toxicity - single exposure (Category 3), Central nervous system, H336
Specific target organ toxicity - single exposure (Category 3), Respiratory system, H335
Specific target organ toxicity - repeated exposure, Oral (Category 2), Liver, Blood, H373
Specific target organ toxicity - repeated exposure, Inhalation (Category 2), Central nervous
system, H373
Label elements
PictogramGHS07 exclam
GHS08 silhouete
2.2 Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram Signal word Warning
Hazard statement(s)
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
H336 May cause drowsiness or dizziness.
H351 Suspected of causing cancer.
H373 May cause damage to organs (Liver, Blood) through prolonged
or repeated exposure if swallowed.
H373 May cause damage to organs (Central nervous system) through
prolonged or repeated exposure if inhaled.
Precautionary statement(s)
P261 Avoid breathing vapours.
P281 Use personal protective equipment as required.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes.
Remove contact lenses, if present and easy to do. Continue
Supplemental Hazard
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent,
bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at
levels of 0.1% or higher.
Synonyms : dichloro(2H2)methane
Formula : CD2Cl2
Molecular weight : 86,95 g/mol
CAS-No. : 1665-00-5
EC-No. : 216-776-0
Component Classification Concentration
Skin Irrit. 2; Eye Irrit. 2;
Carc. 2; STOT SE 3; H315,
H319, H351, H336
<= 100 %
Molecular Weight (g/mol)86.94
FIRST AID MEASURES4.1 Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult
a physician.
4.2 Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section
2.2) and/or in section 11
4.3 Indication of any immediate medical attention and special treatment needed
No data available
FIRE-FIGHTING MEASURES5.1 Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
5.2 Special hazards arising from the substance or mixture
Carbon oxides, Hydrogen chloride gas
5.3 Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
5.4 Further information
No data available
ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Evacuate personnel to safe areas.
For personal protection see section 8.
6.2 Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
6.3 Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in
suitable, closed containers for disposal.
6.4 Reference to other sections
For disposal see section 13
HANDLING AND STORAGE7.1 Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
For precautions see section 2.2.
7.2 Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Containers which are opened must be carefully resealed and kept upright to prevent
Heat sensitive. Store under inert gas. Hygroscopic.
7.3 Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated
EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parameters Ingredients with workplace control parameters 8.2 Exposure controls Appropriate engineering controls Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. Personal protective equipment

Eye/face protection Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching gloves outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.
The selected protective gloves have to satisfy the specifications of Regulation (EU) 2016/425 and the standard EN 374 derived from it.
Body Protection Impervious clothing, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Control of environmental exposure Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.
PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical properties
a) Appearance Form: liquid
b) Odour No data available
c) Odour Threshold No data available
d) pH No data available
e) Melting
point/freezing point
Melting point/range: -96,99 °C
f) Initial boiling point
and boiling range
40 °C - lit.
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid,
No data available
j) Upper/lower
flammability or
explosive limits
Upper explosion limit: 22 %(V)
Lower explosion limit: 14 %(V)
k) Vapour pressure 1.687,3 hPa at 55 °C
470,8 hPa at 20 °C
l) Vapour density 3 - (Air = 1.0)
m) Relative density 1,362 g/cm3 at 25 °C
n) Water solubility slightly soluble
o) Partition coefficient:
No data available
p) Auto-ignition
556,1 °C
662,0 °C q) Decomposition No data available temperature
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
9.2 Other safety information
Relative vapour
3 - (Air = 1.0)
No data available
10.2 Chemical stability
Stable under recommended storage conditions.
10.3 Possibility of hazardous reactions
No data available
10.4 Conditions to avoid
10.5 Incompatible materials
Alkali metals, Aluminum, Strong oxidizing agents, Bases
10.6 Hazardous decomposition products
Hazardous decomposition products formed under fire conditions. - Carbon oxides, Hydrogen
chloride gas
Other decomposition products - No data available
In the event of fire: see section 5
TOXICOLOGICAL INFORMATION11.1 Information on toxicological effects
Acute toxicity
LDLo Oral - Human - 357 mg/kg
Remarks: (RTECS)
LD50 Oral - Rat - male and female - > 2.000 mg/kg
(OECD Test Guideline 401)
LC50 Inhalation - Rat - 4 h - 60,14 mg/l
Remarks: (Lit.)
LD50 Dermal - Rat - male and female - > 2.000 mg/kg
(OECD Test Guideline 402)
Skin corrosion/irritation
Skin - Rabbit
Result: Irritations - 4 h
(OECD Test Guideline 404)
Repeated or prolonged exposure may cause skin irritation and dermatitis, due to
degreasing properties of the product.
Serious eye damage/eye irritation
Eyes - Rabbit
Result: Eye irritation Remarks: (ECHA)
Respiratory or skin sensitisation
Local lymph node assay (LLNA) - Mouse
Result: negative
(OECD Test Guideline 429)
Germ cell mutagenicity
Ames test
Salmonella typhimurium
Result: positive
Mutagenicity (mammal cell test): chromosome aberration.
Chinese hamster ovary cells
Result: positive
OECD Test Guideline 474
Mouse - male and female - Bone marrow
Result: negative
Suspected of causing cancer.
IARC: No component of this product present at levels greater than or equal to 0.1% is
identified as probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
Specific target organ toxicity - single exposure
Inhalation - May cause drowsiness or dizziness. - Central nervous system
Acute oral toxicity - Nausea, Vomiting, Risk of aspiration upon vomiting., Aspiration may
cause pulmonary oedema and pneumonitis.
Acute inhalation toxicity - mucosal irritations
Specific target organ toxicity - repeated exposure
Aspiration hazard
Additional Information Repeated dose toxicity - Rat - male and female - Oral - 104 Weeks - No observed adverse
effect level - 6 mg/kg
Repeated dose toxicity - Rat - male and female - Inhalation - 104 Weeks
RTECS: Not available
Dichloromethane is metabolized in the body producing carbon monoxide which increases
and sustains carboxyhemoglobin levels in the blood, reducing the oxygen-carrying capacity
of the blood., Acts as a simple asphyxiant by displacing air., anesthetic effects, Difficulty in
breathing, Headache, Dizziness, Prolonged or repeated contact with skin may cause:,
defatting, Dermatitis, Contact with eyes can cause:, Redness, Blurred vision, Provokes
tears., Effects due to ingestion may include:, Gastrointestinal discomfort, Central nervous
system depression, Paresthesia., Drowsiness, Convulsions, Conjunctivitis., Pulmonary
edema. Effects may be delayed., Irregular breathing., Stomach/intestinal disorders,
Nausea, Vomiting, Increased liver enzymes., Weakness, Heavy or prolonged skin exposure
may result in the absorption of harmful amounts of material., Abdominal pain, To the best
of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Systemic effects:
After absorption of large quantities: CNS disorders, Drowsiness, Dizziness, drop in blood pressure, Cardiac irregularities,
depressed respiration, inebriation, Unconsciousness, narcosis, respiratory paralysis
Swallowing may result in damage to the following:
Liver, Kidney
The following applies to aliphatic halogenated hydrocarbons in general: systemic effect:
narcosis, cardiovascular disorders. Toxic effect on liver, kidneys.
Other dangerous properties can not be excluded.
This substance should be handled with particular care.
Blood - Irregularities - Based on Human Evidence
Toxicity to fish flow-through test LC50 - Pimephales promelas (fathead minnow) -
193 mg/l - 96 h
Toxicity to daphnia
and other aquatic
static test EC50 - Daphnia magna (Water flea) - 27 mg/l - 48 h
Toxicity to algae static test EbC50 - Pseudokirchneriella subcapitata (green algae) - >
662 mg/l - 96 h
(OECD Test Guideline 201)
Toxicity to bacteria static test EC50 - activated sludge - 2.590 mg/l - 40 min
(OECD Test Guideline 209)
12.2 Persistence and degradability
Biodegradability aerobic - Exposure time 28 d
Result: 68 % - Readily biodegradable.
(OECD Test Guideline 301D)
12.3 Bioaccumulative potential
12.4 Mobility in soil
12.5 Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent,
bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at
levels of 0.1% or higher.
12.6 Other adverse effects
Discharge into the environment must be avoided.
DISPOSAL CONSIDERATIONS13.1 Waste treatment methods
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product
ADR/RID: 1593 IMDG: 1593 IATA: 1593
14.2 UN proper shipping name
IATA: Dichloromethane
14.3 Transport hazard class(es)
ADR/RID: 6.1 IMDG: 6.1 IATA: 6.1
14.4 Packaging group
14.5 Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
14.6 Special precautions for user
No data available
REGULATORY INFORMATION15.1 Safety, health and environmental regulations/legislation specific for the
substance or mixture
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
15.2 Chemical safety assessment
For this product a chemical safety assessment was not carried out
OTHER INFORMATIONThe above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. For lab use only!